261 related articles for article (PubMed ID: 26538004)
21. New therapies in Hodgkin's lymphoma.
Bartlett N
Clin Adv Hematol Oncol; 2004 Feb; 2(2):80, 83. PubMed ID: 16163165
[No Abstract] [Full Text] [Related]
22. Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group.
Eichenauer DA; Plütschow A; Fuchs M; von Tresckow B; Böll B; Behringer K; Diehl V; Eich HT; Borchmann P; Engert A
J Clin Oncol; 2015 Sep; 33(26):2857-62. PubMed ID: 26240235
[TBL] [Abstract][Full Text] [Related]
23. The emerging role for rituximab in the treatment of nodular lymphocyte predominant Hodgkin lymphoma.
Maeda LS; Advani RH
Curr Opin Oncol; 2009 Sep; 21(5):397-400. PubMed ID: 19606035
[TBL] [Abstract][Full Text] [Related]
24. Pediatric Nodular Lymphocyte-predominant Hodgkin Lymphoma: Treatment Recommendations of the GPOH-HD Study Group.
Mauz-Körholz C; Lange T; Hasenclever D; Burkhardt B; Feller AC; Dörffel W; Kluge R; Vordermark D; Körholz D
Klin Padiatr; 2015 Nov; 227(6-7):314-21. PubMed ID: 26356319
[TBL] [Abstract][Full Text] [Related]
25. [Diagnosis and treatment of nodular lymphocyte predominant Hodgkin lymphoma].
Nagai H
Nihon Rinsho; 2012 Apr; 70 Suppl 2():561-7. PubMed ID: 23134016
[No Abstract] [Full Text] [Related]
26. Nodular lymphocyte predominant Hodgkin's disease.
Portlock CS
Cancer Treat Res; 2006; 131():353-62. PubMed ID: 16704176
[No Abstract] [Full Text] [Related]
27. [Standard therapy and research questions in Hodgkin lymphoma].
Suzuki T
Rinsho Ketsueki; 2012 Oct; 53(10):1615-23. PubMed ID: 23037734
[No Abstract] [Full Text] [Related]
28. [Hodgkin lymphoma (Hodgkin disease)].
Naumann UK; Käser L; Vetter W
Praxis (Bern 1994); 2006 Nov; 95(44):1697-703; quiz 1704, 1706. PubMed ID: 17111877
[No Abstract] [Full Text] [Related]
29. Management of nodular lymphocyte predominant Hodgkin lymphoma in the modern era.
King MT; Donaldson SS; Link MP; Natkunam Y; Advani RH; Hoppe RT
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):67-75. PubMed ID: 25863755
[TBL] [Abstract][Full Text] [Related]
30. T-cell/histiocyte-rich large B-cell lymphoma--transformation of nodular lymphocyte predominant Hodgkin lymphoma in the bone marrow.
Eyre TA; King AJ; Hatton C; Collins GP
Eur J Haematol; 2014 Jun; 92(6):550-1. PubMed ID: 24483596
[No Abstract] [Full Text] [Related]
31. Rituximab in lymphocyte-predominant Hodgkin disease.
Azim HA; Pruneri G; Cocorocchio E; Cinieri S; Raviele PR; Bassi S; Preda L; Martinelli G; Peccatori FA
Oncology; 2009; 76(1):26-9. PubMed ID: 19033694
[TBL] [Abstract][Full Text] [Related]
32. XVIII. Management of nodular lymphocyte predominant Hodgkin lymphoma.
Advani RH; Hoppe RT
Hematol Oncol; 2015 Jun; 33 Suppl 1():90-5. PubMed ID: 26062064
[No Abstract] [Full Text] [Related]
33. Progress in the initial management of Hodgkin's Lymphoma.
Marri PR; Ansell SM
Transfus Apher Sci; 2013 Aug; 49(1):12-8. PubMed ID: 23769695
[TBL] [Abstract][Full Text] [Related]
34. Rituximab monotherapy in nodular lymphocyte-predominant Hodgkin's disease.
Boulanger E; Meignin V; Leverger G; Solal-Céligny P
Ann Oncol; 2003 Jan; 14(1):171. PubMed ID: 12488312
[No Abstract] [Full Text] [Related]
35. Hodgkin lymphoma.
Hoppe RT; Advani RH; Ai WZ; Ambinder RF; Bello CM; Bierman PJ; Blum KA; Dabaja B; Duron Y; Forero A; Gordon LI; Hernandez-Ilizaliturri FJ; Hochberg EP; Maloney DG; Mansur D; Mauch PM; Metzger M; Moore JO; Morgan D; Moskowitz CH; Poppe M; Pro B; Weiss L; Winter JN; Yahalom J;
J Natl Compr Canc Netw; 2011 Sep; 9(9):1020-58. PubMed ID: 21917626
[No Abstract] [Full Text] [Related]
36. Intranodular clusters of activated cells with T follicular helper phenotype in nodular lymphocyte predominant Hodgkin lymphoma: a pilot study of 32 cases from Finland.
Nathwani BN; Vornanen M; Winkelmann R; Kansal R; Doering C; Hartmann S; Hansmann ML
Hum Pathol; 2013 Sep; 44(9):1737-46. PubMed ID: 23684509
[TBL] [Abstract][Full Text] [Related]
37. [Differential diagnosis of nodular lymphocyte-predominant Hodgkin lymphoma and lymphocyte-rich classic Hodgkin lymphoma: role of immunohistochemistry].
He YM; Li GD; Li FY; Jiang W; Ji H; Liao DY; Liu WP; Li YC; Li WF; Chen Y; Yang YH; Wang SX; Yang ZR
Zhonghua Bing Li Xue Za Zhi; 2007 Jun; 36(6):416-7. PubMed ID: 17822631
[No Abstract] [Full Text] [Related]
38. Management of Hodgkin lymphoma.
Ansell SM; Armitage JO
Mayo Clin Proc; 2006 Mar; 81(3):419-26. PubMed ID: 16529147
[TBL] [Abstract][Full Text] [Related]
39. Hodgkin's disease of the oesophagus: a literature review.
Jones K; Pacella J; Wasty F
Australas Radiol; 2007 Oct; 51(5):489-91. PubMed ID: 17803804
[TBL] [Abstract][Full Text] [Related]
40. "Popcorn cells" in intraoperative touch imprints of nodular lymphocyte-predominant Hodgkin lymphoma.
Aragao A; Kilic I; Velankar MM; Pambuccian SE
Diagn Cytopathol; 2020 Feb; 48(2):177-180. PubMed ID: 31793243
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
